GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Total Stockholders Equity

BML (BMLKF) Total Stockholders Equity : $859.5 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is BML Total Stockholders Equity?

BML's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $859.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BML's Book Value per Share for the quarter that ended in Dec. 2023 was $22.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BML's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

BML Total Stockholders Equity Historical Data

The historical data trend for BML's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Total Stockholders Equity Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 707.34 813.44 979.92 916.39 840.11

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 916.39 860.99 834.42 859.45 840.11

BML  (OTCPK:BMLKF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BML's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(859.451-0)/38.9841
=22.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BML's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 859.451
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BML's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BML (BMLKF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Total Stockholders Equity
Comparable Companies
TSE:4544 TSE:2395 TSE:2309 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
4694:Japan
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
Website
http://www.bml.co.jp
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.